Briacell Therapeutics Corp Share Price

NASDAQ: BCTX

Small Cap

$8.02

+0.02

(+0.22%)

Live

as on September 16, 2025 at 12:35 am IST

$₹

Briacell Therapeutics Corp Stock Performance

as on September 16, 2025 at 12:35 am IST

Day's Low
Day's High
$8
Day's Price Range
$8.25
$8.02
0.25%
Downside
2.87%
Upside
52 Week's Low
52 Week's High
$6
52-Week Price Range
$214.5
$8.02
25.19%
Downside
2574.56%
Upside

Briacell Therapeutics Corp share price movements today

Previous Close: $8.00
Open: $8.02
Volume: 312.8K
Day's Low - High: $8 - $8.25
52 Week Low - High: $6 - $214.5

Briacell Therapeutics Corp Historical Returns

1 Month Return: + 8.11 %
3 Month Return: -74.36 %
1 Year Return: -90.48 %
3 Year Return: -99.34 %
5 Year Return: 0 %

Briacell Therapeutics Corp Stock Fundamentals & Key Indicators

Check Briacell Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.0M

EPS (TTM)

-2.955

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-24.3M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

3609600.00%

Briacell Therapeutics Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Briacell Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Briacell Therapeutics Corp	BUY	$14.0M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Briacell Therapeutics Corp Stock including INR - Dollar returns

The Briacell Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Briacell Therapeutics Corp investment value today

Current value as on today

₹14,524

Returns

₹85,476

(-85.48%)

Returns from Briacell Therapeutics Corp Stock

₹90,461 (-90.46%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Briacell Therapeutics Corp Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Briacell Therapeutics Corp. Average target price of $95

Briacell Therapeutics Corp Share Price Target

Get share price movements and forecasts by analysts on Briacell Therapeutics Corp.

What analysts predicted

91.56%UPSIDE

Target Price

$95

Current Price

$8.02

Analyzed by

5 Analysts

Target

$95.00

Briacell Therapeutics Corp target price $95, a slight upside of 91.56% compared to current price of $8.02. According to 5 analysts rating.

Briacell Therapeutics Corp Stock's Interest Amongst Investors

Search interest for Briacell Therapeutics Corp Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-53% versus previous 30 day period

Briacell Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Jan 2023	Apr 2023	Jul 2023	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Total Revenue	-	-	-	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	-	-
Operating Income	-4	-5	-7	-8	-9	-9	-5	-5	-7	-6
EBITDA	-4	-5	-2	-8	-9	-9	-5	-5	-7	-6
Interest Expense	15	0	14	-	-	-	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	0	-4	-2	5	-11	1	-1	-5	-6	-6
Income Tax Expense	15	0	0	-14	1	-10	0	-	-	-
Net Income	-11	-4	-2	6	-11	1	-1	-5	-6	-6
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5355.59%	0.00%	0.00%	0.00%

Briacell Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	0	0	-3	-6	-15	-23	0
EBITDA	-5	-5	-3	-6	-34	-22	0
Interest Expense	0	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-5	0	-4	-13	-26	-20	0
Income Tax Expense	0	0	0	6	0	0	0
Net Income	0	0	1	-2	-11	-20	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Briacell Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Apr 2023	Jul 2023	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025
Net Income	-4	-2	5	-11	1	-1	-5	-6	-6
Operating Cash Flow	-5	-10	-7	-7	-5	-4	-6	-5	-7
Investing Cash Flow	-	-	-	-	0	0	0	0	0
Financing Cash Flow	0	4	-	-	-	4	11	5	14
Change in Cash	-5	-6	-7	-7	-5	0	4	0	7

Briacell Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Jul 2016	Jul 2017	Jul 2018	Jul 2019	Jul 2020	Jul 2021	Jul 2022	Jul 2023	Jul 2024
Net Income	-1	-2	-4	-4	-3	0	-26	-20	-4
Operating Cash Flow	-1	-1	-3	-3	-1	-7	-12	-23	-24
Investing Cash Flow	0	0	0	1	-	-	-	-	0
Financing Cash Flow	0	2	4	2	1	64	-3	3	4
Change in Cash	0	0	0	0	0	57	-16	-19	-20

Global Institutional Holdings in Briacell Therapeutics Corp

Funds	Holdings
UBS Group AG	0.01%
Group One Trading, LP	0%
Royal Bank of Canada	0%
Morgan Stanley - Brokerage Accounts	0%
SBI Securities Co Ltd	0%

See all

Insights on Briacell Therapeutics Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 166.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 222.8%
NEGATIVE IMPACT
Price Dip
In the last 3 months, BCTX stock has moved down by -74.4%

About Briacell Therapeutics Corp

briacell therapeutics corp immunotherapy approaches to cancer management briacell is a los angeles headquartered biotechnology company focused on immunotherapy treatments for cancer management. to date, the company has been successful in developing its patented "briavax" vaccine and implementing two compelling fda phase-i studies with late-stage breast cancer patients, demonstrating unique and unprecedented results. briacell is focused on aggressively moving towards launching its next clinical trial, a phase-i/ii study, in order to apply its vaccine to a larger number of breast cancer patients and effectively progress its technology along the value chain. while the current corporate focus is breast cancer, the company has an eye towards potentially applying its vaccine technology to certain other cancer types as well.

Organisation	Briacell Therapeutics Corp
Headquarters	Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
CEO	Dr. William V. Williams FCPA, M.D.
E-voting on shares	Click here to vote

Key Management of Briacell Therapeutics Corp

Name	Title
Dr. Miguel A. Lopez-Lago Ph.D.	Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H., MPH	Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.	Founder, Principal Research Advisor & Member of Scientific Advisory Board
Dr. William V. Williams FCPA, M.D.	CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.	CFO & Corporate Secretary

FAQs

What is Briacell Therapeutics Corp share price today?

Briacell Therapeutics Corp share price today is $8.02 as on September 16, 2025 at 12:35 am IST. Briacell Therapeutics Corp share today touched a day high of $8.25 and a low of $8.

What is the 52 week high and 52 week low for Briacell Therapeutics Corp share?

Briacell Therapeutics Corp share touched a 52 week high of $214.5 on October 1, 2024 and a 52 week low of $6 on August 25, 2025. Briacell Therapeutics Corp stock price today i.e. September 16, 2025 at 12:35 am IST is trending at $8.02,which is 96.26% down from its 52 week high and 33.67% up from its 52 week low.

What is Briacell Therapeutics Corp's market capitalisation today?

Briacell Therapeutics Corp market capitalisation is $0.00T as on September 16, 2025 at 12:35 am IST.

How to invest in Briacell Therapeutics Corp Stock (BCTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Briacell Therapeutics Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Briacell Therapeutics Corp Shares that will get you 0.1870 shares as per Briacell Therapeutics Corp share price of $8.02 per share as on September 16, 2025 at 12:35 am IST.

What is the minimum amount required to buy Briacell Therapeutics Corp Stock (BCTX) from India?

Indian investors can start investing in Briacell Therapeutics Corp (BCTX) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 12:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Briacell Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 12:40 am IST). Based on Briacell Therapeutics Corp share’s latest price of $8.02 as on September 16, 2025 at 12:35 am IST, you will get 1.2469 shares of Briacell Therapeutics Corp. Learn more about fractional shares .